Trials / Completed
CompletedNCT01438281
Study to Evaluate the Ocular Tolerance of SYL1001 in Healthy Volunteers
Phase I Study to Evaluate the Ocular Tolerance of SYL1001 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Sylentis, S.A. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether SYL1001 is safe for the prevention and treatment of ocular pain and dry eye syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SYL1001 | SYL1001 eye drops. topical administration |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2011-11-01
- Completion
- 2012-06-01
- First posted
- 2011-09-22
- Last updated
- 2012-07-17
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01438281. Inclusion in this directory is not an endorsement.